Our findings that GA is significantly elevated relative to HbA1c in certain patients with T2D, may raise serious issues regarding GA as an adequate index for monitoring glycemic control, especially in subjects with longer duration of diabetes, or severely impaired endogenous insulin secretion, such as during type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.